Position in ANIP
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,645,060
-$96,696 QoQ
Shares Held
47,400
0.0% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026OSSIAM holds $11,530,234 across 7 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
126,199 | $5,177,944 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
74,058 | $2,509,085 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
43,300 | $2,046,791 | |
| 4 | ZTS |
Zoetis Inc.
|
16,929 | $1,216,517 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
494 | $267,664 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
1,342 | $226,180 | |
| 7 | VTRS |
Viatris Inc
|
5,419 | $86,053 |
All Filings in ANIP
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,645,060 | 47,400 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,741,756 | 47,400 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,341,840 | 47,400 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||